Novo valuation surpasses Tesla on experimental obesity drug data

Go back to Novo valuation surpasses Tesla on experimental obesity drug data
Lilly (Eli) & Co. (NYSE: LLY) Delayed: 1152.44 --0 (-0%)
Previous Close $1152.44    52 Week High $88.16 
Open $1152.44    52 Week Low $67.88 
Day High $1152.44    P/E 266.77 
Day Low $1152.44    EPS $4.32 
Volume 1,496       

NOVO-NORDISK A/S (NYSE: NVO) Delayed: 43.19 --0 (-0%)
Previous Close $43.19    52 Week High $59.00 
Open $43.19    52 Week Low $32.80 
Day High $43.19    P/E N/A 
Day Low $43.19    EPS $0.00 
Volume 97,897       

ING Van Kampen Equity Growth Fund S 2 Class (NASDAQ: VKTX) Delayed: 29.36 --0 (-0%)
Previous Close $29.36    52 Week High $5.17 
Open $29.36    52 Week Low $0.94 
Day High $29.36    P/E N/A 
Day Low $29.36    EPS $0.00 
Volume 878